Metabolomics Workbench : NIH Data Repository

Clustering data with hclust algorithm for Effects of Zinc on GI tract metabolites (Study ST000330)

Reversed phase POSITIVE ION MODE (Analysis AN000527)

Metabolite	Structure	F1	F2	F3
TG (54:4)	ME116147	0.89	0.41	1.69
DG (36:3)	ME115974	0.63	0.40	1.97
TG (52:4)	ME116137	0.70	0.39	1.91
TG (54:7) B	ME116153	0.27	0.20	2.54
TG (54:6) A	ME116150	0.20	0.24	2.57
TG (54:7) A	ME116152	0.14	0.23	2.63
DG (36:4)	ME115975	0.33	0.35	2.32
TG (54:5) A	ME116148	0.53	0.31	2.16
PC (40:4)	ME116039	0.35	1.06	1.58
SM (d37:1)	ME116092	0.25	1.08	1.67
SM (d38:2)	ME116095	0.14	1.04	1.71
CE (18:3)	ME115962	0.62	1.71	0.67
CE (18:2)	ME115961	0.66	1.35	0.99
CE (18:1)	ME115960	0.28	1.66	1.05
PC (38:2)	ME116030	0.41	1.54	1.05
PC (p-40:1) or PC (o-40:2)	ME116064	2.75	0.10	0.15
GlcCer (d42:1)	ME115982	2.56	0.23	0.21
TG (51:1)	ME116129	2.62	0.24	0.14
TG (49:2)	ME116122	2.43	0.31	0.26
TG (51:3)	ME116131	2.42	0.29	0.29
TG (49:1)	ME116121	2.41	0.35	0.25
TG (51:2)	ME116130	2.42	0.37	0.21
Ceramide (d18:1/23:0)	ME115964	2.18	0.53	0.29
Ceramide (d42:1)	ME115966	2.23	0.51	0.25
Ceramide (d42:2)	ME115967	2.29	0.42	0.29
TG (56:7)	ME116163	2.27	0.40	0.33
GlcCer (d42:2)	ME115983	2.34	0.34	0.32
TG (14:0/14:0/14:0)	ME116111	2.29	0.36	0.35
TG (55:2)	ME116155	2.30	0.36	0.34
GlcCer (d40:1)	ME115981	2.23	0.36	0.41
TG (51:4)	ME116132	2.25	0.35	0.40
PC (30:1)	ME116000	2.18	0.41	0.41
PC (p-42:3) or PC (o-42:4)	ME116069	2.16	0.42	0.42
TG (55:3)	ME116156	2.20	0.42	0.38
TG (49:3)	ME116123	2.23	0.40	0.37
TG (53:2)	ME116140	2.23	0.42	0.35
PC (28:0)	ME115998	2.11	0.42	0.47
TG (53:3)	ME116141	2.13	0.41	0.47
LPC (p-16:0) or LPC (o-16:1)	ME115996	2.10	0.46	0.44
TG (58:3)	ME116167	2.09	0.45	0.46
PC (p-42:4) or PC (o-42:5)	ME116070	2.17	0.37	0.47
TG (58:4)	ME116168	2.17	0.31	0.52
TG (56:5)	ME116161	1.79	0.79	0.43
Acylcarnitine C16:0	ME115955	2.03	0.75	0.22
TG (54:5) B	ME116149	1.88	0.57	0.54
TG (56:1)	ME116157	1.89	0.64	0.48
TG (58:6)	ME116169	2.10	0.59	0.31
Ceramide (d40:1)	ME115965	2.05	0.56	0.38
TG (53:1)	ME116139	2.02	0.61	0.36
TG (56:6)	ME116162	2.03	0.59	0.38
Acylcarnitine C18:1	ME115957	1.99	0.68	0.33
TG (49:0)	ME116120	1.97	0.63	0.40
TG (55:1)	ME116154	1.95	0.62	0.44
CE (16:1)	ME115959	0.94	1.33	0.73
PC (p-34:2) or PC (o-34:3)	ME116055	1.15	1.36	0.49
SM (d36:2)	ME116091	0.60	0.94	1.47
SM (d39:1)	ME116096	0.69	0.97	1.34
SM (d40:2) A	ME116099	0.67	0.95	1.38
SM (d34:2)	ME116088	0.80	0.89	1.31
SM (d38:1)	ME116094	0.80	0.90	1.30
PC (42:6)	ME116047	0.84	0.95	1.21
SM (d36:1)	ME116090	0.80	0.96	1.24
SM (d40:2) B	ME116100	0.81	0.92	1.26
PC (38:4) A	ME116032	0.86	0.98	1.16
SM (d42:3)	ME116107	0.83	1.00	1.17
TG (42:1)	ME116112	0.94	0.94	1.12
PC (36:3) A	ME116020	0.89	0.92	1.19
PC (36:4) B	ME116023	0.90	0.92	1.17
PC (p-40:5) or PC (o-40:6)	ME116066	0.90	0.92	1.18
PE (40:7)	ME116078	1.13	0.65	1.22
TG (52:2)	ME116135	1.13	0.66	1.21
DG (36:2)	ME115973	1.10	0.72	1.18
LPC (16:0)	ME115986	1.12	0.72	1.16
LPC (18:1)	ME115989	1.30	0.64	1.06
TG (50:2)	ME116126	1.22	0.66	1.12
DG (34:2)	ME115971	1.08	0.55	1.38
TG (52:3)	ME116136	1.03	0.54	1.43
TG (52:5)	ME116138	1.21	0.54	1.26
TG (54:3)	ME116146	1.18	0.47	1.35
PC (37:2)	ME116027	1.04	1.10	0.86
PC (42:7)	ME116048	1.08	1.10	0.82
PC (35:4)	ME116017	0.98	1.04	0.99
PE (p-40:5) or PE (o-40:6)	ME116083	0.99	1.04	0.97
DG (38:3)	ME115976	1.07	1.03	0.90
SM (d33:1)	ME116085	1.05	1.01	0.94
Cholesterol	ME115968	0.94	1.02	1.04
PC (37:4)	ME116029	0.91	1.01	1.08
PC (38:3)	ME116031	0.95	0.98	1.07
PC (38:5) A	ME116034	1.05	0.93	1.03
SM (d34:1)	ME116087	1.04	0.93	1.03
PC (40:7)	ME116044	1.01	0.96	1.03
PE (p-38:5) or PE (o-38:6)	ME116082	1.00	0.94	1.06
SM (d36:0)	ME116089	1.00	0.95	1.05
SM (d40:1)	ME116098	1.00	0.84	1.16
SM (d41:2)	ME116102	1.02	0.86	1.11
PC (40:5) A	ME116040	1.01	0.89	1.10
PC (p-36:4) or PC (o-36:5)	ME116059	1.00	0.90	1.09
TG (50:1)	ME116125	1.19	0.79	1.02
PC (38:5) B	ME116035	1.14	0.78	1.08
PC (p-38:5) or PC (o-38:6)	ME116063	1.18	0.76	1.06
SM (d38:0)	ME116093	1.08	0.82	1.09
LPC (18:0)	ME115988	1.16	0.83	1.01
SM (d41:1)	ME116101	1.13	0.83	1.04
SM (d42:2) A	ME116105	1.12	0.83	1.05
LPC (20:4)	ME115994	1.14	0.86	1.01
SM (d32:1)	ME116084	1.11	0.86	1.02
PC (p-38:4) or PC (o-38:5) A	ME116061	1.11	0.89	1.01
PE (38:4)	ME116076	1.09	0.90	1.02
PE (p-38:4) or PE (o-38:5)	ME116081	1.14	0.90	0.95
DG (38:5)	ME115977	1.11	0.92	0.97
PE (p-36:4) or PE (o-36:5)	ME116080	1.11	0.92	0.97
PC (p-40:6) or PC (o-40:7) B	ME116068	1.09	0.94	0.96
SM (d34:0)	ME116086	1.10	0.94	0.96
PC (p-38:4) or PC (o-38:5) B	ME116062	1.12	1.03	0.84
PC (36:4) A	ME116022	1.13	0.99	0.88
PC (40:6) A	ME116042	1.11	0.98	0.90
Gal-Gal-Cer(d18:1/16:0) or Lactosylceramide(d18:1/16:0)	ME115980	1.15	0.95	0.90
PC (36:4) C	ME116024	1.16	0.92	0.92
PC (35:1)	ME116014	1.17	1.07	0.76
PC (35:2)	ME116015	1.19	1.04	0.77
LPC (20:0)	ME115991	1.19	0.99	0.82
PC (35:3)	ME116016	1.18	1.00	0.81
PC (p-34:1) or PC (o-34:2) A	ME116053	1.27	0.97	0.76
PE (p-36:2) or PE (o-36:3)	ME116079	1.23	0.98	0.79
TG (50:0)	ME116124	1.24	0.96	0.80
PC (38:7)	ME116037	1.36	0.98	0.66
PC (36:3) B	ME116021	1.26	1.03	0.71
TG (58:8)	ME116170	1.27	1.04	0.69
PC (33:2)	ME116008	1.40	0.90	0.70
PC (p-36:1) or PC (o-36:2)	ME116056	1.38	0.88	0.74
PC (40:8)	ME116045	1.30	0.91	0.79
PC (p-32:0) or PC (o-32:1)	ME116051	1.32	0.90	0.78
PE (36:1)	ME116075	1.38	0.83	0.79
TG (48:0)	ME116116	1.33	0.85	0.82
PC (40:6) B	ME116043	1.28	0.76	0.95
DG (38:6) B	ME115979	1.30	0.79	0.91
PC (p-38:3) or PC (o-38:4)	ME116060	1.31	0.78	0.91
PC (34:0)	ME116009	1.34	0.78	0.87
DG (38:6) A	ME115978	1.35	0.75	0.89
PC (p-36:2) or PC (o-36:3)	ME116057	1.33	0.75	0.92
PC (42:5)	ME116046	1.22	0.80	0.98
PC (39:6)	ME116038	1.24	0.80	0.96
PC (40:5) B	ME116041	1.24	0.80	0.96
PC (p-40:6) or PC (o-40:7) A	ME116067	1.23	0.82	0.95
SM (d42:2) B	ME116106	1.23	0.81	0.96
PC (p-36:3) or PC (o-36:4)	ME116058	1.20	0.87	0.93
PC (p-40:4) or PC (o-40:5)	ME116065	1.21	0.84	0.95
PC (32:0)	ME116002	1.26	0.86	0.88
PC (38:4) B	ME116033	1.26	0.87	0.87
PC (34:4)	ME116013	1.28	0.84	0.87
PC (37:3)	ME116028	1.29	0.86	0.85
PC (36:2)	ME116019	1.21	0.94	0.85
PC (34:1)	ME116010	1.22	0.88	0.90
PC (34:2)	ME116011	1.21	0.91	0.88
CE (20:4)	ME115963	1.23	0.89	0.88
PC (36:1)	ME116018	1.22	0.90	0.88
Acylcarnitine C18:0	ME115956	1.54	1.16	0.30
TG (56:8)	ME116164	1.63	0.99	0.29
SM (d44:2)	ME116110	1.99	0.44	0.57
TG (54:6) B	ME116151	1.95	0.44	0.61
TG (56:3)	ME116159	1.95	0.36	0.69
PC (p-34:1) or PC (o-34:2) B	ME116054	1.97	0.27	0.76
TG (56:4)	ME116160	1.95	0.29	0.76
SM (d42:0)	ME116103	1.87	0.36	0.88
TG (53:4)	ME116142	1.84	0.41	0.75
LPC (p-18:0) or LPC (o-18:1)	ME115997	1.54	0.41	1.05
LPC (20:1)	ME115992	1.61	0.47	0.92
TG (53:5)	ME116143	1.64	0.43	0.93
PC (36:5) A	ME116025	1.73	0.43	0.84
TG (54:2)	ME116145	1.67	0.53	0.80
LPC (16:1)	ME115987	1.74	0.55	0.71
LPC (o-16:0)	ME115995	1.77	0.52	0.71
TG (56:2)	ME116158	1.85	0.50	0.65
LPC (14:0)	ME115984	1.82	0.53	0.65
SM (d43:2)	ME116109	1.81	0.53	0.65
DG (32:1)	ME115969	1.73	0.60	0.68
TG (58:2)	ME116166	1.78	0.59	0.63
PC (32:3)	ME116005	1.76	0.60	0.64
TG (46:0)	ME116113	1.74	0.61	0.65
PC (32:1)	ME116003	1.72	0.65	0.63
Acylcarnitine C18:2	ME115958	1.68	0.66	0.66
TG (48:2)	ME116118	1.70	0.63	0.67
PC (o-32:0)	ME116049	1.69	0.64	0.67
PC (o-34:0)	ME116050	1.69	0.63	0.68
PC (32:2)	ME116004	1.82	0.60	0.58
TG (54:1)	ME116144	1.79	0.62	0.58
TG (46:1)	ME116114	1.77	0.70	0.53
PC (34:3)	ME116012	1.75	0.68	0.57
PE (34:3)	ME116074	1.76	0.65	0.59
SM (d42:1)	ME116104	1.43	0.70	0.87
LPC (18:2)	ME115990	1.45	0.68	0.88
TG (50:3)	ME116127	1.46	0.68	0.86
SM (d40:0)	ME116097	1.46	0.75	0.79
SM (d43:1)	ME116108	1.46	0.76	0.78
DG (36:1)	ME115972	1.40	0.76	0.84
PE (38:6)	ME116077	1.38	0.76	0.85
DG (34:1)	ME115970	1.43	0.60	0.97
TG (50:4)	ME116128	1.56	0.59	0.86
LPC (20:2)	ME115993	1.50	0.61	0.89
PC (38:6) A	ME116036	1.50	0.59	0.91
TG (48:1)	ME116117	1.58	0.71	0.72
TG (60:2)	ME116172	1.60	0.70	0.70
PC (p-44:4) or PC (o-44:5)	ME116072	1.61	0.66	0.73
LPC (15:0)	ME115985	1.65	0.64	0.71
PC (30:0)	ME115999	1.65	0.66	0.69
TG (46:2)	ME116115	1.56	0.65	0.79
TG (52:1)	ME116134	1.59	0.62	0.79
PC (p-34:0) or PC (o-34:1)	ME116052	1.54	0.70	0.76
TG (48:3)	ME116119	1.52	0.68	0.80
PC (31:0)	ME116001	1.64	0.74	0.61
TG (58:1)	ME116165	1.62	0.78	0.60
TG (58:9)	ME116171	1.59	0.79	0.61
PC (33:1)	ME116007	1.52	0.85	0.63
TG (52:0)	ME116133	1.46	0.85	0.69
PC (33:0)	ME116006	1.51	0.81	0.69
PC (36:5) B	ME116026	1.50	0.81	0.70
PC (p-42:5) or PC (o-42:6)	ME116071	1.51	0.76	0.73
PE (34:2)	ME116073	1.51	0.77	0.72

Factors:

F1	Treatment:Zn-Deficient
F2	Treatment:Zn-replenished
F3	Treatment:Zn-sufficient

Data matrix